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Background: There are incomplete data on the global burden of viral lower respiratory tract infection, in particular
the role of Respiratory Syncytial Virus, in children requiring health services.
Findings: In this study set in a large urban area of southern China from 1 January 2007 to 31 December 2010, children
1 month to 14 years of age with RSV-associated “severe” or “very severe pneumonia” according to World Health
Organization definitions, and meeting local criteria for admission to the pediatric intensive care unit, were followed for
the course of their admission. The median age was 3 months and 79% (135/171) of children with RSV were under
six months of age. All children needed supplemental oxygen, and 22% required mechanical ventilatory support. The
mortality rate was 3.5%. In multivariate analysis, congenital heart disease and Trisomy 21 were associated with death.
Conclusions: Children admitted to an intensive care unit with RSV-associated severe/very pneumonia in a large
urban setting in southern China were most commonly ≤ six months old and almost one quarter of these had
respiratory failure. The overall mortality rate was 3.5%. RSV vaccine strategies that would protect children from
early infancy are urgently needed.
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Background
RSV is the most common viral cause of acute lower re-
spiratory tract infection (ALRI) in developed and devel-
oping countries [1,2]. RSV-associated ALRI manifests
clinically as bronchiolitis and/or pneumonia. Children
are admitted to hospital if respiratory distress prevents
adequate feeding or if respiratory support is needed. In
the developing world 3 to 9% of ALRI deaths are
thought to be due to RSV [1].
In ambulatory and general ward settings in China RSV
has been identified in 23 to 38% of children with ALRI
[3-7], but there are little data on those ill enough to be ad-
mitted to an intensive care unit. In a study of severe and
very severe community acquired pneumonia (S/VS-CAP)
due to any cause in southern China we found that young
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reproduction in any medium, provided the orwere associated with pediatric intensive care unit (PICU)
admission [8]. In this report we describe the subset of
children with RSV, in order to determine the burden of
morbidity and mortality with this common virus that
could be alleviated by vaccines or other interventions.
Study methods
The Children’s Hospital affiliated with Soochow Univer-
sity is the only referral centre for children less than
14 years of age in Suzhou city (pop 13 million, 2010),
and has 25,000 pediatric admissions yearly. A prospect-
ive study of severe and very severe pneumonia, of any
microbial etiology, was conducted in the PICU from 1
January 2007 to 31 December 2010; methods have been
published [8]. In brief, eligible children were 1 month to
14 years of age, met WHO criteria for severe pneumonia
or very severe pneumonia [9], and were enrolled within
24 hours of PICU admission at this hospital. Exclusion-
ary criteria were refusal of parental consent to parti-
cipate, or presence of pre-existing chronic illness, or a
co-morbidity leading to admission.
Demographic and clinical information were collected by
parental interview and review of the health record usingLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Children 1 month through 14 years of age with
severe/very severe community acquired pneumonia
attributable to Respiratory Syncytial virus (RSV) requiring
admission to a pediatric intensive care unit (PICU)















2007-2008 399 123 34 (27.6) 1/34 (2.9%)
2008-2009 486 133 31 (23.3) 1/31 (3.2%)
2009-2010 539 192 46 (24) 2/46 (4.3%)
2010-2011 692 259 60 (23) 2/60 (3.3%)
Total 2116 707 171 (24) 6/171 (3.5%)
ALRI – acute lower respiratory tract infection; WHO =World Health Organization.
Mixed viral infections are not reported here.
Figure 1 Seasonality of RSV-associated severe/very severe
pneumonia admissions (n=171) to the pediatric intensive care
unit (2007–2010).
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and nasopharyngeal aspirate (NPA) for diagnosis of RSV,
influenza virus A and B, para-influenza 1, 2, and 3 and
adenovirus (Direct Immunofluorescence assay, Chemicon
International – Millipore, Bellerica, Mass) were obtained.
Subgroups of RSV (A, B) were not assessed. In this study
we describe the subset of children with laboratory con-
firmed RSV infection.
Clinical management followed a predetermined protocol
[8]. The criteria for assisted ventilation included inability to
maintain a saturation of >90% on an FIO2 of >70%, apnea,
hypercarbia with acidemia and clinical assessment of
impending exhaustion [8].
Statistical analysis consisted of description of categor-
ical variables, and comparisons of children with RSV
that died or survived were made using multivariate ana-
lysis. P <0.05 was considered statistically significant. All
analyses were performed using SPSS 13.0 software (IBM,
Armonk, NY).
The study was approved by the Research Ethics Board
of the Children’s Hospital affiliated with Soochow Uni-
versity and written informed consent was obtained from
the parent/guardian of each child.
Results
RSV was confirmed in 57% (171/295) of all children with
viral severe or very severe community acquired pneumonia
[8], and accounted for 24% of these PICU admissions (171/
707) during the three year study period. Other viruses iden-
tified were influenza (19%; 56/295), para-influenza (11%; 32/
295) and adenovirus (3.4%; 10/295). Viral co-infection
occurred in 26 children; 21 of these included RSV infection.
The median age of RSV-infected PICU admissions was
3 months, with 79% (135/171) of patients being under
6 months of age (range 1 month-3 years). Males com-
prised 122 (71%) of cases. Pre-existing conditions were
congenital heart disease (CHD) in 15% (n = 26), (4 of
these patients also had Trisomy 21), followed by prema-
ture birth (n = 18; 10.5%). Nine children had Trisomy 21
alone as a risk factor, and a neurodevelopmental condi-
tion was present in 5.3% (n = 9). Over half of children
were previously healthy with no risk factors for severe
RSV illness (53%; 90/171).
Clinical features at presentation were similar over the
three years, with all children presenting with cough, inter-
costal recession and tachypnea. Other symptoms (e.g. fever,
lethargy) were variably present (data not shown). Although
all children required supplemental oxygen, only 22% (37/
171) required assisted ventilatory support. The average
length of stay in the PICU was 5 days (range 3, 26 days).
The RSV mortality rate was 3.5% (Table 1). Death was
associated with CHD (Odds Ratio (OR) 34.29, 95% con-
fidence interval (CI) 3.82, 307.98, p = 0.00), and Trisomy
21 (OR 11.29, 95% CI 1.76, 72.39; p = 0.35). CHD wasthe only significant predictor of a PICU stay longer than
7 days) (OR 4.67, 95% CI 1.95,11.16; p < 0.001).
The RSV season was consistent each year (Figure 1),
with an annual epidemic from November to February.
Discussion
In this study of pediatric intensive care unit admissions
in a large Chinese city RSV was the etiologic agent in
24% of all episodes of severe/very severe pneumonia.
This is likely an underestimate of the burden due to
RSV because of several possible limitations. Firstly, given
limited resources, we used an immunofluorescent viral
diagnostic technique rather than a more sensitive, and
expensive, molecular diagnostic technique (e.g. polymer-
ase chain reaction, PCR). Secondly, PICU admission cap-
tures only the severe end of the spectrum of RSV illness.
Finally, although our centre is the only care setting to
which severely ill children would present in our area, it
is possible that children could succumb before present-
ing to hospital, or not present for care because the fam-
ily could not afford to pay 20% of the cost of hospital
admission. The findings are also limited by our inability
to perform subgroup typing (RSV A and B).
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that seen in developed countries rather than in the devel-
oping world [1,2], but higher than that found in a study in
Hong Kong [10]. We found both congenital heart disease
and Trisomy 21 were associated with mortality. In some
western countries children at high risk for severe RSV
illness, such as those with hemodynamically significant
heart disease or premature birth may be offered passive
immunization with the anti-RSV monoclonal antibody
palivizumab [2,11]. While such a strategy, in which chil-
dren receive monthly intramuscular injections of mono-
clonal antibody, is feasible in children with known risk
factors in some countries, it is not feasible for most of the
world’s children. Young age is a known vulnerability for
severe RSV [2], and over this four-year study 79% of RSV
cases were less than 6 months of age. Over half of the
PICU admissions for RSV were in previously healthy chil-
dren. These epidemiologic features point to the need for a
strategy that would be available to all infants early in life.
A vaccine given in late pregnancy or in early infancy
would be necessary to benefit these young infants.
The November to February epidemics of RSV coincides
with the colder months in this “humid, subtropical” region
of China when the average temperature is 5 to 8 degrees
Celsius. RSV activity increases in the winter months in
temperate climates but may occur year around in equator-
ial areas and in tropical and subtropical areas or be more
common in the wet season.
In summary we observed that RSV is a significant cause
of life-threatening acute respiratory illness, particularly in
the first year of life in this population. Passive immunization
is too resource intensive to be feasible preventive strategy
for RSV illness in this population. RSV vaccines are under
investigation and are urgently needed to protect the very
young infant.
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